Cardiovascular Patho 1 Ogena

download Cardiovascular Patho 1 Ogena

of 87

Transcript of Cardiovascular Patho 1 Ogena

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    1/87

    Cardiovascula

    r System

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    2/87

    Pathophysiologic

    Concepts

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    3/87

    Thrombus

    A thrombus

    a blood clot that can develop

    anywhere in the vascular system causing the narrowing of a vessel.

    blood flow can be occluded

    (reduced or totally blocked)

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    4/87

    Thrombus develop from any injury to the vessel wall

    endothelial cell injury draws platelets and other

    mediators of inflammation to the area.

    substances stimulate clotting and activation of the

    coagulation cascade.

    formation can occur when blood flow through a vessel

    is sluggish,

    when blood flow is irregular or erratic

    during periods of irregular heartbeat or cardiac arrest

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    5/87

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    6/87

    Thrombus

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    7/87

    Embolus

    Embolus

    a substance that travels in the

    bloodstream from a primary site to a

    secondary site becomes trapped in the vessels at the

    secondary site

    causes blood flow obstruction.

    Most emboli are blood clots

    (thromboemboli)

    usually deep leg veins

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    8/87

    Other sources of emboli fat

    released during the break of a long bone

    produced in response to any physical trauma, and

    amniotic fluid

    which may enter maternal circulation during the

    intense pressure gradients generated by labor

    contractions.

    Air and displaced tumor cells also may act as emboli to

    obstruct flow.

    Embolus

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    9/87

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    10/87

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    11/87

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    12/87

    Aneurysm Aneurysm

    is a dilation of the arterial wall caused by a

    congenital or developed weakness in the wall.

    Weakness in the wall may develop as a result of an

    infection, from trauma, or, more commonly, from

    lesions produced by atherosclerosis.

    Aneurysms may burst with increased pressure,

    leading to massive internal hemorrhage.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    13/87

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    14/87

    Alterations in Capillary Forces

    of Filtration or Reabsorption

    Occasionally, forces favoring filtration

    from the capillary into the interstitial

    fluid are greater than forces favoring

    reabsorption of fluid into the capillaryfrom the interstitial space.

    The result is net filtration.

    Net filtration across the capillary

    results in interstitial edema.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    15/87

    Alterations in Capillary Forces of

    Filtration or Reabsorption

    The opposite occurs when forces favoring

    reabsorption of fluid from the interstitial

    space into the capillary are greater than

    those favoring filtration. This results in net reabsorption, which

    leads to increased plasma volume, stroke

    volume, and cardiac output.

    Blood pressure may be increasedsignificantly.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    16/87

    Causes of Increased Capillary

    Filtration

    Causes of increased capillary filtration include

    increased capillary pressure

    caused by high blood pressure

    increased capillary leakage

    caused by injury or inflammation. increase in protein concentration in the

    interstitial fluid

    caused by increased capillary breakdown

    decreased lymph flow to the area would

    also cause net filtration, leading to edemaand swelling of the interstitial space.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    17/87

    Causes of Increased

    Capillary Filtration

    Causes of increased capillary filtration

    include

    decreased production or increased

    loss of plasma proteins

    reduce the reabsorption of fluid

    back into the capillary.

    can occur with liver disease orloss of protein in the urine.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    18/87

    Causes of Increased

    Capillary Reabsorption Causes of increased

    reabsorption of fluid from theinterstitial space include

    decreased blood pressure inthe capillary due to a decrease in

    systemic pressure or

    constriction of the arterioleor precapillary sphincter.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    19/87

    Increased plasma colloid osmotic pressurealso draws fluid back into the capillary.

    Plasma colloid osmotic pressure increaseswith dehydration, leading to a return of fluid

    from the interstitium to the plasma, whichhelps return plasma volume toward normal.

    Finally, increased interstitial fluid pressureincreases reabsorption by opposing furtheraccumulation of fluid.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    20/87

    Stenosis

    Stenosis

    a narrowing of any vessel or opening.

    stenosis of the heart valves may

    occur.

    congenital defect or an inflammatory

    process (e.g., after rheumatic fever).

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    21/87

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    22/87

    Results of Cardiac Valve

    Stenosis

    chamber upstream of the stenosispumping more forcefully to expel itsblood through the narrowed orifice.

    After years of this extra work,cardiac muscle can hypertrophy(increase in size).

    If the chamber cannot pump

    forcefully enough to overcome thestenosis, blood flow out of thechamber will be reduced.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    23/87

    Results of Cardiac Valve

    Stenosis

    chamber increases its oxygenconsumption and energy demands.

    The coronary arteries supplying themuscle may be unable to supply adequate

    oxygen to meet this demand. blood may accumulate in the chamber

    and stretch its muscle fibers.

    If this is significant or prolonged, a

    decrease in muscle contractility can result.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    24/87

    Examples of Cardiac Valve Stenosis

    Any cardiac valve

    Mitral stenosis

    narrowing of the valve between the left atriumand left ventricle.

    Aortic stenosis

    narrowing of the valve between the leftventricle and the aorta.

    Tricuspid stenosis

    narrowing of the valve between the rightatrium and the right ventricle.

    Pulmonary stenosis narrowing of the valve between the right

    ventricle and the pulmonary artery.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    25/87

    Valve Incompetence

    An incompetent valve is one that

    does not close completely, allowing

    blood to move in both directionsthrough that valve when the heart

    contracts (valve regurgitation).

    Any of the cardiac valves may be

    incompetent.

    Each chamber may hypertrophy.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    26/87

    Cardiac Shunts

    a shunt is a connection between thepulmonary vascular system and thesystemic vascular system.

    During fetal life, shunts between the right

    and left sides of the heart and between theaorta and pulmonary artery are normal.

    The direction blood flows through a shuntis determined by resistance to flow in eachdirection.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    27/87

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    28/87

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    29/87

    Right-to-Left Shunt

    the flow of blood from the right side of theheart to the left, or from the pulmonary arteryto the systemic circulation.

    After birth, right heart and pulmonary artery

    blood is poorly oxygenated. Therefore, a right-to-left shunt delivers poorly oxygenated bloodto the systemic circulation.

    called a cyanotic shunt because delivery of

    poorly oxygenated blood to the systemiccirculation causes cyanosis (bluish tinge tothe skin).

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    30/87

    Left-to-Right Shunt

    the flow of blood from the left side ofthe heart to the right side, or from theaorta to the pulmonary circulation.

    Left heart blood is well oxygenated. Blood going to the lungs from the leftside of the heart recirculates to theleft atrium and left ventricle.

    Because the blood is well-oxygenated, this shunt is acyanotic.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    31/87

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    32/87

    Two Types of Cardiac Defects

    Congenital

    Anatomic>abnormal function

    Acquired

    Disease process

    Infection

    Autoimmune response

    Environmental factors

    Familial tendencies

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    33/87

    Causes of CHD

    Chromosomal/genetic = 10%-12% Maternal or environmental = 1%-2%

    Maternal drug use Fetal alcohol syndrome50% have CHD

    Maternal illness Rubella in 1st 7 wks of pregnancy50%

    risk of defects including PDA andpulmonary branch stenosis

    CMV, toxoplasmosis, other viral

    illnesses>> cardiac defects IDMs = 10% risk of CHD (VSD,

    cardiomyopathy, TGA most common) Multifactorial = 85%

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    34/87

    CHD

    Incidence: 5-8 per 1000 live births About 2-3 of these are symptomatic in first year

    of life Major cause of death in first year of life (after

    prematurity)

    Most common anomaly is VSD 28% of kids with CHD have another recognized

    anomaly (trisomy 21, 13, 18, +++ )

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    35/87

    Older Classifications of CHD

    Acyanotic

    May become cyanotic

    Cyanotic May be pink

    May develop CHF

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    36/87

    Newer Classification ofCHD

    Hemodynamic characteristics

    Increased pulmonary blood

    flow

    Decreased pulmonary blood

    flow

    Obstruction of blood flow out

    of the heart

    Mixed blood flow

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    37/87

    Increased Pulmonary

    Blood Flow Defects

    Abnormal connection between

    two sides of heart

    Either the septum or the great

    vessels

    Increased blood volume on

    right side of heart

    Increased pulmonary blood flow

    Decreased systemic blood flow

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    38/87

    Increased Pulmonary

    Blood Flow Defects

    Atrial septal defect

    Ventricular septal defect

    Patent ductus arteriosus

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    39/87

    ATRIAL SEPTAL DEFECT (ASD)

    Abnormal opening between the atria

    an abnormal opening between the left and

    right atria.

    foramen ovale fails to close after birth, or

    when another opening between the left

    and right atria is present due to improper

    closure of the wall between the two atria

    during gestation.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    40/87

    PATHOPHYSIOLOGY

    Blood flows from left to the

    right

    Increase flow of oxygenated

    blood nto the right side of the

    heart

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    41/87

    ASD

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    42/87

    CLINICAL MANIFESTATIONS

    Asymptomatic

    May develop congestive heart

    failure Murmur

    Atrial dysrhythmias

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    43/87

    VENTRICULAR SEPTAL

    DEFECT (VSD)

    Abnormal opening between

    right and left ventricle

    the most common cardiac

    congenital defect

    May close spontaneously : 1st

    year of life

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    44/87

    VSD

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    45/87

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    46/87

    PATHOPHYSIOLOGY

    Blood flow from higher pressure

    left ventricle to low pressure

    right ventricle

    Increased blood volume is

    pumped into the lungs

    Right ventricular hypertrophy

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    47/87

    CLINICAL MANIFESTATIONS

    Murmur

    Congestive heart failure iscommon

    C S

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    48/87

    PATENT DUCTUSARTERIOSUS

    Failure of the fetal ductus

    arteriosus (artery connecting

    aorta and pulmonary artery) to

    close within the first weeks oflife

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    49/87

    PATHOPHYSIOLOGY

    Blood flow from high pressure

    aorta to lower pressure pulmonary

    artery Increased workload on the left side

    of the heart

    Hypertrophy

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    50/87

    PDA

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    51/87

    CLINICAL

    MANIFESTATIOn

    AymptomaticSigns of congestive heart

    failure

    Machinery-like murmur

    Widened pulse pressure

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    52/87

    Obstructive Defects

    Coarctation of the aorta

    Aortic stenosis

    Pulmonic stenosis

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    53/87

    COARCTATION OF THE AORTA

    (COA)

    Localized narrowing near the

    insertion of the ductus

    arteriosus,

    increased pressure proximal to

    the defect

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    54/87

    COA

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    55/87

    CLINICAL MANIFESTATION

    High BP and bounding pulses inarms

    Weak or absent femoral pulses

    Cool lower extremities Low BP in the lower extremities Dizziness Headache

    FaintingEpistaxis

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    56/87

    Aortic Stenosis

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    57/87

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    58/87

    Aortic Stenosis

    a narrowing in the opening of the valve betweenthe left ventricle and the aorta.

    follows rheumatic fever or is a congenitalmalformation.

    ventricle must pump more forcefully to expel

    blood through the narrow orifice. This causes ventricular hypertrophy and

    eventually reduces compliance. As blood backsup in the ventricle, atrial pressure increases and

    blood backs up into the pulmonary system andthe right side of the heart.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    59/87

    Clinical Manifestations

    Clinical manifestations may be absent or severe,depending on the level of stenosis.

    Pulmonary congestion, with signs of dyspnea andpulmonary hypertension, may occur if blood backs upinto the pulmonary vascular system.

    Dizziness and fatigue may occur due to decreasedcardiac output and decreased stroke volume. Heartrate may be elevated via sympathetic stimulation.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    60/87

    Diagnostic Tools

    A systolic heart murmur may

    be heard as blood rushes

    through the narrow orifice.

    Echocardiography may be

    used to diagnose abnormal

    valve structure and motion.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    61/87

    Complications

    Left ventricular hypertrophy may

    develop, leading to congestive

    heart failure. Treatment

    Treatment for congestive heart

    failure may be required.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    62/87

    Pulmonic Stenosis

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    63/87

    Pulmonic Stenosis

    a narrowing of the opening between theright ventricle and the pulmonary valve.

    most commonly occurs due to a congenitaldefect.

    With a narrow orifice, the right ventriclemust pump more forcefully to expel blood.This can lead to right ventricularhypertrophy, backing up into the right

    atrium and causing dilation of the venacava and blood accumulation in thesystemic veins.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    64/87

    Blood flow into the lungs andleft side of the heart will bereduced if the stenosis is

    severe, leading to a decreasein blood pressure. Right heartfailure may develop.

    Clinical

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    65/87

    ClinicalManifestations

    may be absent or severe depending

    on the level of stenosis.

    Decreased pulmonary flow causes

    poor oxygenation of the blood andfeelings of weakness and fatigue.

    Venous distention and swelling of the

    ankles and feet are common.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    66/87

    Diagnostic Tools

    Echocardiography may be used to diagnose

    abnormal valve structure and motion. Complications

    Right heart hypertrophy and subsequent rightheart failure may occur.

    Treatment

    Treatment for heart failure may be required. Valve replacement or surgical correction of

    the stenosis may be attempted.

    Decreased Pulmonary

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    67/87

    Decreased PulmonaryBlood Flow Defects

    Tetralogy of Fallot

    Tricuspid atresia

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    68/87

    Tetralogy of Fallot

    The classic form includes

    four defects

    Ventricular septal defectPulmonic stenosis

    Overriding of the aorta

    Right ventricular

    hypertrophy

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    69/87

    Tetralogy of Fallot

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    70/87

    Tetralogy of Fallot

    CLINICAL MANIFESTATIONS

    Infants

    Cyanotic at birth

    Episodes of cyanosis

    and hypoxia called Blue

    or tet spells

    Crying or after feeding

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    71/87

    Tricuspid Atresia

    Tricuspid Atresia

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    72/87

    Tricuspid Atresia

    The deformity consists of a

    complete lack of formation of the

    tricuspid valve with absence of

    direct connection between theright atrium and right ventricle.

    prevalence of 0.3-3.7% in

    patients with congenital heartdisease

    Clinical

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    73/87

    ClinicalManifestation

    detected in infancy because ofpresenting cyanosis, congestiveheart failure, and growth

    retardation. history of poor skin colorationinability to complete a feedingsession, frequent pauses during

    feeding, and/or frank anorexia.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    74/87

    Clinical Manifestation

    As a result, the infantdemonstrates poor growthpatterns.

    Respiratory difficulties areoften reported as nasalflaring or muscle retractions

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    75/87

    Mixed Defects

    Transposition of great

    vessels

    Total anomalous pulmonaryvenous connection

    Hypoplastic heart syndrome

    RightLeft

    Transposition of

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    76/87

    Transposition ofGreat Vessels

    The pumonary artery

    arised from the left

    ventricle and the aortaexits from the right

    ventricle

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    77/87

    Transposition of Great Vessels

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    78/87

    CLINICAL MANIFESTATION

    Depend on the type and size of

    associated defects

    Minimal communication Severely cyanotic and depressed at

    birth

    Large septal defects Less cyanotic but may have

    symptoms of CHF

    Totally Anomalous Pulmonary

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    79/87

    Totally Anomalous Pulmonary

    Venous Connection

    Rare Defect.

    Pulmonary veins fail to join L atrium.

    Clinical manifestations: Usually

    cyanotic early on. Condition rapidly

    deteriorates as pulmonaryblood flow

    increases and causes CHF.

    Totally Anomalous Pulmonary

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    80/87

    Totally Anomalous Pulmonary

    Venous Connection

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    81/87

    Hypoplastic Left Heart

    L side of heart is underdeveloped.

    L ventricle is small and aortic atresia.

    Most blood flows across patent foramen

    ovale to R atrium..to R ventricle and out thepulmonary artery.

    Descending aorta receives blood from the

    PDA to supply the systemic circulation. PDAclosure >>rapid deterioration and CHF.

    Hypoplastic Left

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    82/87

    Hypoplastic LeftHeart

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    83/87

    Clinical Manifestations

    As the ductus arteriosus begins to closenormally over the first 24-48 hours of life

    Symptoms of cyanosis, tachypnea,respiratory distress, pallor, lethargy,

    metabolic acidosis, and oliguria develop. Without intervention to reopen the ductus

    arteriosus, death rapidly ensues.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    84/87

    Clinical Manifestations

    With a right-to-left shunt,cyanosis, fatigue, and

    weakness occur. Knee-to-chest

    or squatting behavior may beobserved. Clubbing of the digits

    may develop.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    85/87

    Clinical Manifestations

    With a left-to-right shunt,pulmonary congestion and

    dyspnea may occur. Left heart

    failure may develop.

    Treatment

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    86/87

    Some defects may be small, require no treatment, or close

    spontaneously. Surgical correction of the defect is often required.

    Treatment for congestive heart failure may be necessary.

    Prostaglandin E is administered to maintain patency of the

    ductus arteriosus in preductal coarctation.

    Administration of the prostaglandin inhibitor indomethacin will

    initiate closure of the ductus in patent ductuctus arteriosus.

  • 8/14/2019 Cardiovascular Patho 1 Ogena

    87/87